Immunovant, Inc. (IMVT)
26.66
-0.06
(-0.22%)
USD |
NASDAQ |
Mar 06, 16:00
26.65
-0.01
(-0.04%)
After-Hours: 20:00
Immunovant EPS Diluted (Quarterly) : -0.6095 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Viridian Therapeutics, Inc. | -1.080 |
| Plus Therapeutics, Inc. | -0.0412 |
| Nutriband, Inc. | -0.3212 |
| Definium Therapeutics, Inc. | -0.5106 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -110.64M |
| Total Expenses (Quarterly) | 110.64M |
| Enterprise Value | 4.432B |
| Earnings Yield | -10.06% |
| Normalized Earnings Yield | -10.06 |